Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Deans

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Stem Cells Translational Medicine|July 10, 2013
Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppressionElke Eggenhofer, Felix C Popp, Michael Mendicino, et al.
Trials|November 16, 2012
Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantationJohannes Dillmann, Felix C Popp, Barbara Fillenberg, et al.
Frontiers in Immunology|September 20, 2021
Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects <i>via</i> Adult Progenitor Cell Co-CultureJames L Reading, Valerie D Roobrouck, Caroline M Hull, et al.
Plos One|October 30, 2023
Leveraging a smartphone to perform time-gated luminescence measurementsBrian E Fratto, Emma L Culver, Gabriel Davis, et al.
Nature Biomedical Engineering|April 24, 2019
Biomanufacturing for clinically advanced cell therapiesAyesha Aijaz, Matthew Li, David Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2015
Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2James L Reading, Bart Vaes, Caroline Hull, et al.
Circulation|March 29, 2007
Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodelingLepeng Zeng, Qingsong Hu, Xiaohong Wang, et al.
Journal of Translational Medicine|July 30, 2011
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)Felix C Popp, Barbara Fillenberg, Elke Eggenhofer, et al.
Cytotherapy|October 15, 2010
A changing time: the International Society for Cellular Therapy embraces its industry membersRobert Deans, Kurt C Gunter, Timothy Allsopp, et al.
Stem Cells and Development|December 22, 2017
Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem CellsRaf Donders, Jeroen F J Bogie, Stylianos Ravanidis, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Stem Cells Translational Medicine|July 10, 2013
Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppressionElke Eggenhofer, Felix C Popp, Michael Mendicino, et al.
Trials|November 16, 2012
Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantationJohannes Dillmann, Felix C Popp, Barbara Fillenberg, et al.
Frontiers in Immunology|September 20, 2021
Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects <i>via</i> Adult Progenitor Cell Co-CultureJames L Reading, Valerie D Roobrouck, Caroline M Hull, et al.
Plos One|October 30, 2023
Leveraging a smartphone to perform time-gated luminescence measurementsBrian E Fratto, Emma L Culver, Gabriel Davis, et al.
Nature Biomedical Engineering|April 24, 2019
Biomanufacturing for clinically advanced cell therapiesAyesha Aijaz, Matthew Li, David Smith, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2015
Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2James L Reading, Bart Vaes, Caroline Hull, et al.
Circulation|March 29, 2007
Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodelingLepeng Zeng, Qingsong Hu, Xiaohong Wang, et al.
Journal of Translational Medicine|July 30, 2011
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)Felix C Popp, Barbara Fillenberg, Elke Eggenhofer, et al.
Cytotherapy|October 15, 2010
A changing time: the International Society for Cellular Therapy embraces its industry membersRobert Deans, Kurt C Gunter, Timothy Allsopp, et al.
Stem Cells and Development|December 22, 2017
Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem CellsRaf Donders, Jeroen F J Bogie, Stylianos Ravanidis, et al.
Pageof 5